Trial Profile
A phase II proof-of-concept trial of huperzine A in patients with epilepsy.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 22 May 2013
Price :
$35
*
At a glance
- Drugs Huperzine A (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 17 May 2013 This trial is expected to be initiated by early 2014, according to a Insero Health media release.
- 19 Dec 2012 New trial record